缺血性和非缺血性心肌病的外科治疗.ppt

non-transplantsurgic altreatmentforischemicandnon-ischemiccardioyopathy、hayamaharrtcentrertadashi some ura、jyojiCurrenotropionincardiology 1997，12336934，ICM : LV remodeling，DCM，nomrpreplivg，非技术DCM，CAG.EVCPP(Dor)，SAVE， plv (Batista)，lvr，indicationforsave，indicationforplv，SAVE(seption for plv)11533600 1563-1570 preventionofchfinthecommunity-ammarkaetal。1，0，0.2，2，3，4，5，6，7，survival rate，0.4，0.6，0.8，1.0，years，years11533600 1563-1570 preventionofchfinthecommunity-ammarkaetal。1，0，0.2，2，3，4，5，6，7，survival rate，0.4，0.6，0.8，1.0，years，years126:0-7，0.4，estimateofsurvival，57，ef35%，n=，20.3%，55.7%，Conclusion :Survival rate (%)，1.0，0.1，0.2，0.3，0.4，0.5，0.6，0.7，0.8，0.9，0.0，1234566，modifiedbatistaoperationindication=posterolatrakinesis withrspeckletrackingecho 1 . partialleftventriculetomyattheposterioriorspapillary musc leplication(preservationapapillarymusc-mitralvalvecontinuity)3。cryolationattheckandmitralannulus(prevention ofmacro-reentry)，mid-sax；Circumferential stratin、pre、post、lengthening、lengthening、shortening、shortcening、intra-operative evolume test formr、volume reduction、volume loading、presncofmr、surgic altreatmentforischemicmr，themitraltrigonedoseditate。JTC 124no.6116-1224、LV dilation、ischemia、LV edp、Twundersizengannuloplasty=improveannulardilateionpapilasty，conclusion 2-1，Surgic altreatmentforischemicornon-is